|
20 Mar 2025, 9:33
|
Casein kinase 1: From cell signaling to therapeutic targets in human disease
Dear colleagues, industrial partners and investors,
we would like to attract your attention to the MILESTONE International Conference CK1 protein kinase family: From cell signaling to therapeutic targets in human disease. This, first ever solely CK1-focused conference aims to become a platform to discuss the progress in preclinical development of CK1 inhibitors and degraders.
The conference that will take place in July 21-23, 2025 in Brno, Czech Republic, will bring together world-wide experts from academia and industry working on various aspects of CK1 preclinical and early phase clinical research.
Visit, learn about the invited speakers and register at 🔗 https://ck1.sci.muni.cz/
We warmly invite you to join us and be part of this inspiring scientific gathering.
We are looking to welcome you or your team members in Brno!
Vitezslav Bryja & Konstantinos Tripsianes (local organizers)
|
|
|
|
Scientific committee
Kathy Gould, Vanderbilt University, USA
Carrie Partch, University of California Santa Cruz, USA
VÃtÄ›zslav Bryja, Masaryk University, Czech Republic
Pascal Marchand, Nantes University, France
Gopal Sapkota, University of Dundee, UK
Uwe Knippschild, University of Ulm, Germany
Najma Rachidi, Institut Pasteur, France
Konstantinos Tripsianes, Brno, Czech Republic
|
|
|
|
Invited speakers
David Virshup, Duke-NUS, Singapore
Volker Dötsch, Goethe University Frankfurt, Germany
Yinon Ben-Neriah, The Hebrew University of Jerusalem, Israel
David Strutt, University of Sheffield, UK
Stefan Knapp, SGC Frankfurt, Germany
Andrea Venerando, University of Udine, Italy
Lorenzo Pinna, University of Padova, Italy
|
|
|
|
|
|